Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Campath-1H · 1 trial · 2 indications
| Arm | Type | Description |
|---|---|---|
| Campath-1H | EXPERIMENTAL | 30 mg IV three times a week, 6-12 weeks. |
| Name | Type | Description |
|---|---|---|
| Campath-1H | DRUG | Participant will receive three test doses of Campath-1H (3, 10, and 30mg). If this is tolerated then they will receive Campath-IH three times a week for 6 weeks. |
Inclusion Criteria: * Diagnosis of lymphoplasmacytic lymphoma including patients with Waldenstrom's macroglobulinemia * Adequate organ function: ANC \> 500/ul; PLT \> 25,000/ul; serum creatinine \< 2.5; serum total bilirubin and SGOT \< 2.5 times the upper normal limit. * Age greater than 18 years ...